28 articles for JB Baell
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Structural Basis for the Selective Binding of Inhibitors to 6-Hydroxymethyl-7,8-dihydropterin Pyrophosphokinase from Staphylococcus aureus and Escherichia coli.

Monash University
Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS).

Monash University (Parkville Campus)
Structure-based design and development of functionalized Mercaptoguanine derivatives as inhibitors of the folate biosynthesis pathway enzyme 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus.

Monash University
Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL.

Genentech
De-novo designed library of benzoylureas as inhibitors of BCL-XL: synthesis, structural and biochemical characterization.

The Walter and Eliza Hall Institute of Medical Research
Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL.

The Walter and Eliza Hall Institute of Medical Research
Synthesis and biological evaluation of chalcones as inhibitors of the voltage-gated potassium channel Kv1.3.

The Walter and Eliza Hall Institute of Medical Research
Identification of 5,6-substituted 4-aminothieno[2,3-d]pyrimidines as LIMK1 inhibitors.

The Walter and Eliza Hall Institute of Medical Research
Quinazoline sulfonamides as dual binders of the proteins B-cell lymphoma 2 and B-cell lymphoma extra long with potent proapoptotic cell-based activity.

The Walter and Eliza Hall Institute of Medical Research
Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity.

Monash University (Parkville Campus)
Discovery of novel and potent benzhydryl-tropane trypanocides highly selective for Trypanosoma cruzi.

Institute of Medical Research
Omega-conotoxin GVIA mimetics based on an anthranilamide core: effect of variation in ammonium side chain lengths and incorporation of fluorine.

The University of Queensland
The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonists.

Monash University
Drug discovery and optimization based on the co-crystal structure of natural product with target.

Anhui Medical University
Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening.

Institute of Medical Research
Development of [

Monash University
A new class of blockers of the voltage-gated potassium channel Kv1.3 via modification of the 4- or 7-position of khellinone.

Institute of Medical Research Biotechnology Centre
A three-residue, continuous binding epitope peptidomimetic of ShK toxin as a Kv1.3 inhibitor.

Institute of Medical Research
Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity.

Institute of Medical Research Biotechnology Centre
Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazines.

University of Melbourne
Synthesis and evaluation of pyridine-derived bedaquiline analogues containing modifications at the A-ring subunit.

Monash University (Parkville Campus)
Design, Synthesis, and Characterization of Cyclic Peptidomimetics of the Inducible Nitric Oxide Synthase Binding Epitope That Disrupt the Protein-Protein Interaction Involving SPRY Domain-Containing Suppressor of Cytokine Signaling Box Protein (SPSB) 2 and Inducible Nitric Oxide Synthase.

Monash University
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents.

Monash University (Parkville Campus)
Development of Benzenesulfonamide Derivatives as Potent Glutathione Transferase Omega-1 Inhibitors.

Monash University
Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A.

Cancer Therapeutics Crc
Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists.

Monash University
Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example.

Monash University
Synthesis and target identification of hymenialdisine analogs.

Genomics Institute of The Novartis Research Foundation